I always miss the QR code part
But yeah, looks like my question and yours were answered later on, Janoshik was provided with a reference by AR, and tested it against said reference. As much as Janoshik is a highly, highly valued part of this greater overall community, he is exactly one single part of it: Does provided sample contain what the test request is looking to see if it contains?
FWIW part of me also figures that if such a substance could be created, and had anything close to what is claimed for effectiveness...Big Pharma would (rightfully so arguably) have been all over it. If semi-random vendor can have a lab create this, so could any of Big Pharma. Only obstacle I can think of there would be if it infringes on the patents for S or T, that would stop them from it.
As a devil's advocate response, I'd like some sort of Phase 1 testing on a compound at absolute bare minimum, and in particular having that testing rather than being charged for the "privilege" of being the Phase 1 tester myself, which is basically what this is.
What even would a researcher dose this as? If it is a molecule that is part S and part T, well, on a milligram basis those doses are very different. 2.5mg is the T starting dose. 2.5mg is the current S long-term dose. Should someone administer 0.25mg? 2.5mg? In between? More? Less?
At least after a Phase 2 trial, a researcher would have a halfway decent idea of what dosage and schedule for administration may or may not cause whatever set of desired effects and unwanted side effects one is comfortable with.